The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
公司代碼TOI
公司名稱Oncology Institute Inc
上市日期Mar 13, 2020
CEOVirnich (Daniel)
員工數量825
證券類型Ordinary Share
年結日Mar 13
公司地址18000 Studebaker Rd
城市CERRITOS
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編90703
電話15627353226
網址https://theoncologyinstitute.com/
公司代碼TOI
上市日期Mar 13, 2020
CEOVirnich (Daniel)